JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AMAG
1926
DELISTED
AMAG Pharmaceuticals
AMAG
| $11.6M | ﹤0.01% |
878,381
+332,215
| +61% | +$5.01M |
2013 Q2
18 quarters
|
|
1927
CAE Inc
CAE
$7.74B
| $11.6M | ﹤0.01% |
626,130
-432,450
| -41% | -$7.65M |
2014 Q4
12 quarters
|
|
1928
The Bancorp
TBBK
$2B
| $11.6M | ﹤0.01% |
1,170,610
+1,069,247
| +1,055% | +$9.8M |
2017 Q3
1 quarter
|
|
1929
CALL
JD.com
JD
$35.6B
| $11.5M | ﹤0.01% |
278,400
| – | – |
2016 Q1
7 quarters
|
|
|
CZZ
1930
DELISTED
Cosan Limited
CZZ
| $11.5M | ﹤0.01% |
1,187,256
+397,150
| +50% | +$3.59M |
2015 Q2
10 quarters
|
|
1931
Kemper
KMPR
$1.53B
| $11.5M | ﹤0.01% |
167,022
+42,323
| +34% | +$2.73M |
2015 Q1
11 quarters
|
|
1932
TransUnion
TRU
$11.9B
| $11.5M | ﹤0.01% |
209,365
-20,490
| -9% | -$1.09M |
2016 Q1
7 quarters
|
|
1933
Ingevity
NGVT
$2.44B
| $11.5M | ﹤0.01% |
163,168
+41,564
| +34% | +$3M |
2016 Q2
6 quarters
|
|
1934
Universal Insurance Holdings
UVE
$1.2B
| $11.5M | ﹤0.01% |
419,815
+41,838
| +11% | +$1.05M |
2015 Q1
11 quarters
|
|
1935
Timken Company
TKR
$8.25B
| $11.4M | ﹤0.01% |
232,661
-177,336
| -43% | -$8.58M |
2013 Q2
18 quarters
|
|
|
APTI
1936
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $11.4M | ﹤0.01% |
485,941
+78,779
| +19% | +$1.67M |
2017 Q3
1 quarter
|
|
1937
Canadian Solar
CSIQ
$765M
| $11.4M | ﹤0.01% |
677,182
+508,067
| +300% | +$8.73M |
2013 Q3
17 quarters
|
|
1938
Future Fuel
FF
$220M
| $11.4M | ﹤0.01% |
810,205
+8,017
| +1% | +$119K |
2013 Q2
18 quarters
|
|
1939
PUT
Skyworks Solutions
SWKS
$12.5B
| $11.4M | ﹤0.01% |
120,200
| – | – |
2017 Q1
3 quarters
|
|
1940
CALL
Eli Lilly
LLY
$1.02T
| $11.4M | ﹤0.01% |
135,100
+87,600
| +184% | +$7.45M |
2016 Q3
5 quarters
|
|
|
CLVS
1941
DELISTED
Clovis Oncology, Inc.
CLVS
| $11.4M | ﹤0.01% |
167,417
+98,271
| +142% | +$6.87M |
2013 Q2
18 quarters
|
|
|
AXE
1942
DELISTED
Anixter International Inc
AXE
| $11.4M | ﹤0.01% |
149,556
+20,832
| +16% | +$1.53M |
2013 Q2
18 quarters
|
|
1943
Mine Safety
MSA
$6.91B
| $11.4M | ﹤0.01% |
146,601
+58,999
| +67% | +$4.71M |
2015 Q4
8 quarters
|
|
1944
Mitsubishi UFJ Financial
MUFG
$255B
| $11.3M | ﹤0.01% |
1,560,580
-424,725
| -21% | -$2.9M |
2013 Q2
18 quarters
|
|
|
RPT
1945
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $11.3M | ﹤0.01% |
769,630
-7,856
| -1% | -$109K |
2013 Q2
18 quarters
|
|
|
MPVD
1946
DELISTED
Mountain Province Diamonds Inc.
MPVD
| $11.3M | ﹤0.01% |
4,119,807
-716,399
| -15% | -$2.05M |
2013 Q2
18 quarters
|
|
|
CSR
1947
Centerspace
CSR
$913M
| $11.3M | ﹤0.01% |
199,020
+168,601
| +554% | +$10M |
2016 Q4
4 quarters
|
|
|
EFII
1948
DELISTED
Electronics for Imaging
EFII
| $11.3M | ﹤0.01% |
381,851
+175,016
| +85% | +$5.86M |
2015 Q4
8 quarters
|
|
1949
Vanguard Health Care ETF
VHT
$18.8B
| $11.3M | ﹤0.01% |
73,136
+11,124
| +18% | +$1.71M |
2013 Q2
18 quarters
|
|
1950
PUT
Chipotle Mexican Grill
CMG
$40.9B
| $11.3M | ﹤0.01% |
1,950,000
+580,000
| +42% | +$3.46M |
2017 Q2
2 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.